XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.150
-0.020 (-0.92%)
Sep 28, 2026, 12:46 PM EDT - Market open
XBiotech Market Cap
XBiotech has a market cap or net worth of $65.55 million as of September 28, 2026. Its market cap has decreased by -20.35% in one year.
Market Cap
65.55M
Enterprise Value
-43.98M
1-Year Change
-20.35%
Ranking
Category
Stock Price
$2.15
ChartMarket Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $65.55M, a decrease of -91.11%. That is a compound annual growth rate of -19.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 65.55M | -10.08% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 70.24M |
| Kalaris Therapeutics | 69.51M |
| Champions Oncology | 68.20M |
| Connect Biopharma Holdings | 68.01M |
| Pliant Therapeutics | 66.88M |
| Gossamer Bio | 66.85M |
| Alps Group | 65.89M |
| MindWalk Holdings | 65.01M |